ACB
Aurora Cannabis Inc
NASDAQ · Pharmaceuticals
$3.48
+0.17 (+5.14%)
Income Statement
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 69.57M | 70.84M | 65.30M |
| Net Income | 9.88M | 13.06M | 12.20M |
| EPS | — | — | — |
| Profit Margin | 14.2% | 18.4% | 18.7% |
| Rev Growth | +1.6% | +2.1% | +23.7% |
Balance Sheet
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Total Debt | 20.22M | 23.51M | 23.98M |
| Total Equity | 141.28M | 146.45M | 147.96M |
| D/E Ratio | 0.14 | 0.16 | 0.16 |
Cash Flow
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| EBITDA | 20.53M | 20.07M | 20.48M |
| Free Cash Flow | 10.78M | 11.95M | 8.74M |